Mylan enjoined from bringing Lialda generic to market

30-01-2017

Mylan enjoined from bringing Lialda generic to market

Photo courtesy of Mylan

Mylan's plans to bring a generic version of Shire's bowel disease drug Lialda (mesalamine) to market were shut down when a district court judge held that the action would infringe Shire's patent. 


Mylan, Shire, Lialda, ANDA, FDA, patent

LSIPR